Hologic Q2 2024 Adj EPS $1.03 Beats $0.98 Estimate, Sales $1.017B Beat $1.002B Estimate
Portfolio Pulse from Benzinga Newsdesk
Hologic, Inc. (NASDAQ:HOLX) reported Q2 2024 adjusted earnings of $1.03 per share, surpassing the consensus estimate of $0.98, and sales of $1.017 billion, also beating the estimate of $1.002 billion. However, both earnings and sales saw a slight decrease compared to the same period last year.
May 02, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Hologic's Q2 2024 earnings and sales exceeded analyst expectations, indicating strong performance despite slight year-over-year declines.
Beating both earnings and sales estimates typically leads to positive investor sentiment and can drive the stock price up in the short term. Despite the year-over-year declines, the outperformance against analyst expectations is a strong positive signal.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100